BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17544004)

  • 1. Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy.
    Rousseau J; Boudou C; Estève F; Elleaume H
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):943-51. PubMed ID: 17544004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.
    Adam JF; Joubert A; Biston MC; Charvet AM; Peoc'h M; Le Bas JF; Balosso J; Estève F; Elleaume H
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):603-11. PubMed ID: 16338098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment.
    Adam JF; Biston MC; Rousseau J; Boudou C; Charvet AM; Balosso J; Estève F; Elleaume H
    Phys Med; 2008 Jun; 24(2):92-7. PubMed ID: 18407772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry.
    Adam JF; Biston MC; Joubert A; Charvet AM; Le Bas JF; Estève F; Elleaume H
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1173-82. PubMed ID: 15752899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral delivery of 5-iodo-2'-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma.
    Rousseau J; Adam JF; Deman P; Wu TD; Guerquin-Kern JL; Gouget B; Barth RF; Estève F; Elleaume H
    J Synchrotron Radiat; 2009 Jul; 16(Pt 4):573-81. PubMed ID: 19535873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer gel dosimetry for synchrotron stereotactic radiotherapy and iodine dose-enhancement measurements.
    Boudou C; Troprès I; Rousseau J; Lamalle L; Adam JF; Estève F; Elleaume H
    Phys Med Biol; 2007 Aug; 52(16):4881-92. PubMed ID: 17671341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
    Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
    Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas.
    Adam JF; Elleaume H; Joubert A; Biston MC; Charvet AM; Balosso J; Le Bas JF; Estève F
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1413-26. PubMed ID: 14630281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours.
    Boudou C; Balosso J; Estève F; Elleaume H
    Phys Med Biol; 2005 Oct; 50(20):4841-51. PubMed ID: 16204876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment planning for a synchrotron-based radiotherapy modality.
    Manolopoulos S; Wojnecki C; Green S; Hugtenburg RP; Jones B
    Appl Radiat Isot; 2009 Mar; 67(3):492-4. PubMed ID: 18778946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
    Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monochromatic minibeams radiotherapy: from healthy tissue-sparing effect studies toward first experimental glioma bearing rats therapy.
    Deman P; Vautrin M; Edouard M; Stupar V; Bobyk L; Farion R; Elleaume H; Rémy C; Barbier EL; Estève F; Adam JF
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e693-700. PubMed ID: 22270173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment plans optimization for contrast-enhanced synchrotron stereotactic radiotherapy.
    Edouard M; Broggio D; Prezado Y; Estève F; Elleaume H; Adam JF
    Med Phys; 2010 Jun; 37(6):2445-56. PubMed ID: 20632555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue.
    Bräuer-Krisch E; Serduc R; Siegbahn EA; Le Duc G; Prezado Y; Bravin A; Blattmann H; Laissue JA
    Mutat Res; 2010; 704(1-3):160-6. PubMed ID: 20034592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Kawabata S; Sferra TJ; Bandyopadhyaya AK; Tjarks W; Ferketich AK; Moeschberger ML; Binns PJ; Riley KJ; Coderre JA; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2006 Jun; 12(12):3792-802. PubMed ID: 16778107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
    Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA
    Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute perfusion measurements and associated iodinated contrast agent time course in brain metastasis: a study for contrast-enhanced radiotherapy.
    Obeid L; Deman P; Tessier A; Balosso J; Estève F; Adam JF
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):638-45. PubMed ID: 24447951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the zonal organization of tumor perfusion and permeability in a rat glioma model by using dynamic contrast-enhanced synchrotron radiation CT.
    Balvay D; Troprès I; Billet R; Joubert A; Péoc'h M; Cuenod CA; Le Duc G
    Radiology; 2009 Mar; 250(3):692-702. PubMed ID: 19095783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.